💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for MannKind Corporation (MNKD)
« Back to company indexMNKD Chatter Timeline
Stock Ticker for MNKD
Most Active Tweeters for MNKD
| User | Tweets |
|---|---|
| @OldschoolToday | 18 |
| @TradeWithAlerts | 10 |
| @choppercjk | 9 |
| @Bid_Slap | 8 |
| @newsfilterio | 5 |
Recent Tweets for MNKD
 |
@Holdingdipbuyer RT @HarveySpecTrade: Mannkind $MNKD has not had success thus far in marketing their inhaled formulation of Technosphere insulin, but this p… 1:08am |
 |
@patten1962 @TheVoz4Real $MNKD But recent news has been great. Very excited about this one! 1:08am |
 |
@HarveySpecTrade Mannkind $MNKD has not had success thus far in marketing their inhaled formulation of Technosphere insulin, but thi… https://t.co/tA24TWfwYd 1:08am |
 |
@kim77204419 RT @patten1962: #Covid_19 is here and people are still getting sick. Now $MNKD & $NRXP Have a drug that will help people. #Zyesami #StockMa… August 4th 2021, 9:08pm |
 |
@slullyman Watching Analyst Target Price and Volume on $MNKD >: https://t.co/zQyZYlVi6g >: https://t.co/mSXWVFBY0l August 4th 2021, 9:08pm |
 |
@SmallCapsDaily $MNKD NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI (aviptadil) Inhaler for Respiratory… https://t.co/W7HaNObdHK August 4th 2021, 4:08pm |
 |
@pratikonroll RT @MarcJacksonLA: $NRXP $MNKD NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respirato… August 4th 2021, 4:08pm |
 |
@choppercjk RT @StckPro: $MNKD NEW ARTICLE : MannKind Corporation to Hold 2021 Second Quarter Financial Results Conference Call on August 11, 2021 http… August 4th 2021, 4:08pm |
 |
@Bid_Slap @OptionsHawk You know $MNKD gets double digit royalties from $UTHR Tyvaso, right? August 4th 2021, 4:08pm |
|
@Bid_Slap @OptionsHawk Are you now a bull on $MNKD? August 4th 2021, 4:08pm |
 |
@TradeWithAlerts Large Print $MNKD Size: 186331 Price: 4.09 Time: 1201 Amount: $762,093.79 - Delayed - For real time prints subscrib… https://t.co/BDkNU8oCQy August 4th 2021, 4:08pm |
|
@TradeWithAlerts Large Print $MNKD Size: 268600 Price: 4.09 Time: 1156 Amount: $1,098,574.00 - Delayed - For real time prints subscr… https://t.co/IwUVnTCSHv August 4th 2021, 3:08pm |
|
@TradeWithAlerts Large Print $MNKD Size: 268600 Price: 4.09 Time: 1155 Amount: $1,098,574.00 - Delayed - For real time prints subscr… https://t.co/p7Gr1vyhm3 August 4th 2021, 3:08pm |
|
@patten1962 #Covid_19 is here and people are still getting sick. Now $MNKD & $NRXP Have a drug that will help people. #Zyesami… https://t.co/nsVbWy68dN August 4th 2021, 3:08pm |
 |
@OldschoolToday $MNKD ...anyway you slice it this is truly a gift here with what they have coming imo August 4th 2021, 3:08pm |
 |
@certunicorns $MNKD looking into this further when I have more time (currently in work) but nice thread filled with DD https://t.co/FYKf045Hao August 4th 2021, 3:08pm |
|
@Bid_Slap @Pharmdca Does this mean you are buying $MNKD? That would fit your strategy Would appreciate an answer ? August 4th 2021, 2:08pm |
 |
@MarcJacksonLA $NRXP $MNKD NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Resp… https://t.co/2SBQemJx6D August 4th 2021, 2:08pm |
|
@OldschoolToday $MNKD = Monster in the Making imo August 4th 2021, 2:08pm |
|
@OldschoolToday $MNKD ..think we are gonna have one hell of a rest of the year here !! August 4th 2021, 2:08pm |
|
@choppercjk RT @SilvioDanailov: #AFREZZA is a great product. Needles out! $MNKD long ! https://t.co/kGoARtKgy6 August 4th 2021, 2:08pm |
|
@choppercjk RT @BWcapital_: $MNKD good news out today about another possible partnership. I loaded more today down here at 4.00 $4.00 is still only ap… August 4th 2021, 2:08pm |
|
@choppercjk RT @OpenOutcrier: $NRXP (+3.8% pre) MannKind $MNKD Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (avipt… August 4th 2021, 2:08pm |
|
@choppercjk RT @stock_titan: $MNKD $NRXP NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory… August 4th 2021, 2:08pm |
 |
@Gularfnm $MNKD MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based… https://t.co/pZnhVALudd August 4th 2021, 2:08pm |
 |
@BWcapital_ $MNKD good news out today about another possible partnership. I loaded more today down here at 4.00 $4.00 is still… https://t.co/meZqprB5SA August 4th 2021, 2:08pm |
 |
@_Jedi_Night @Briefingcom Technosphere Inhaler for “Inflammatory conditions” ….. $MNKD #Covid August 4th 2021, 1:08pm |
 |
@John_galt1111 $NRXP: NRx Pharmaceuticals has signed an agreement with MannKind Corporation $MNKD to develop a dry powder formulation of ZYESAMI (16.02) August 4th 2021, 1:08pm |
|
@_Jedi_Night $MNKD Ok some smart Big Pharma better make the move now and swallow them up while it’s so cheap. Some hidden val… https://t.co/f9cJZBwtnY August 4th 2021, 12:08pm |
|
@OldschoolToday $MNKD ....DO NOT Bet Against $MNKD !! August 4th 2021, 12:08pm |
|
@OldschoolToday $MNKD Newsfilter shared an idea on Stocktwits https://t.co/IvMItAJECt August 4th 2021, 12:08pm |
 |
@newsfilterio NRx Pharmaceuticals and MannKind team up to develop a dry powder formulation of ZYESAMI $NRXP $MNKD https://t.co/J1vMJVU3nR August 4th 2021, 12:08pm |
 |
@MikeRob22492309 $MNKD https://t.co/WSI1r1Uvg0 Rapid recovery from Critical COVID-19 with Respiratory Failure has been reported in p… https://t.co/CWG970szdN August 4th 2021, 12:08pm |
 |
@ethanFlare $MNKD - NRx Pharmaceuticals and MannKind team up to develop a dry powder formulation of ZYESAMI Cap size: small, Fl… https://t.co/L5Qbr9wCTI August 4th 2021, 12:08pm |
 |
@MarketCurrents $MNKD $NRXP - NRx Pharmaceuticals and MannKind team up to develop a dry powder formulation of ZYESAMI https://t.co/EvM8lsCz5R August 4th 2021, 12:08pm |
 |
@JeffTheOmega1 $MNKD Got my eye on the high SI ticker with covid news https://t.co/d7lKscnwS3 August 4th 2021, 12:08pm |
|
@patten1962 $MNKD Big news! Wondering when @CathieDWood And @ARKInvest jumps in on the disruptive technology for $ARKK ?… https://t.co/IcPKszRxW4 August 4th 2021, 12:08pm |
|
@OldschoolToday $MNKD ...Nice News with a Good Company !!! August 4th 2021, 12:08pm |
 |
@OpenOutcrier $NRXP (+3.8% pre) MannKind $MNKD Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™… https://t.co/6NX4Yc0LBG August 4th 2021, 12:08pm |
|
@John_galt1111 $NRXP $MNKD: NRx Partners with MannKind Corporation to Develop ZYESAMI™ ([vcpt[^cl) Inb[l_r `or R_spcr[tory Con^ctc… https://t.co/PjLOBfRdIj August 4th 2021, 12:08pm |
 |
@Dagger_Six ?MannKind Corporation $MNKD has partnered with NRx Pharmaceuticals $NRXP (NRx) to evaluate the feasibility of formu… https://t.co/IxKUCpRHOU August 4th 2021, 11:08am |
 |
@zerofiltertruth Another good move by $MNKD - rightfully bouncing off 200/day https://t.co/QbcSInDQnp August 4th 2021, 11:08am |
 |
@otcdynamics $MNKD NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respirator… https://t.co/MSMO1gMXpo August 4th 2021, 11:08am |
|
@otcdynamics $MNKD MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil) Based… https://t.co/CiyIRNaZUo August 4th 2021, 11:08am |
 |
@FlashAlert_me $MNKD [15s. delayed]: Issued Press Release on August 04, 06:48:00: MannKind Partners With NRx Pharmaceuticals To Ex… https://t.co/o6HSvpuOqt August 4th 2021, 10:08am |
 |
@ZoZoStockwatch RT @TheTradeXchange: $NRXP $MNKD: NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respir… August 4th 2021, 10:08am |
 |
@StockNewsBot2 $MNKD $NRXP MannKind Partners With NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI™ (aviptadil)… https://t.co/z6E41MXPe9 August 4th 2021, 10:08am |
|
@StockNewsBot2 $MNKD $NRXP NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Resp… https://t.co/xHLgD4Mjo1 August 4th 2021, 10:08am |
 |
@roscopusa NRx Pharmaceuticals Partners with MannKind Corporation to Develop ZYESAMI™ (aviptadil) Inhaler for Respiratory Conditions $NRXP $MNKD August 4th 2021, 10:08am |
|
@newsfilterio NRx Pharmaceuticals Partners with MannKind to Develop ZYESAMI™ Inhaler for Respiratory Conditions $MNKD $NRXP https://t.co/Vb2RQBjwMm August 4th 2021, 10:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?